The diagnosis and treatment options for testicular carcinoma from Dr. Shanzah Shahbaz, a medical oncologist. This comprehensive guide covers staging, tumor markers, false elevation risks, chemotherapy regimens, and management of residual masses.

2 views • 15 slides

This study by the Proton Collaborative Group evaluates the outcomes of proton beam therapy for hepatocellular carcinoma across multiple institutions. Factors such as liver tolerance, baseline function, and prior therapies were considered in the treatment of liver cancer. The study emphasizes the imp

0 views • 22 slides

Kate Gregory leads the SWAG Protocols update for March 2024, with advancements in new protocols and NICE TA updates. A comparison of activities from Oct 2023 to Mar 2024 shows progress in issuing, reviewing, and drafting protocols. The latest NICE TA additions include treatments for advanced cancers

5 views • 13 slides

A case study discusses a 69-year-old woman with a history of stable diabetes facing elevated HbA1c levels despite normal fasting glucose. Initial investigations, including a day curve test, reveal high postprandial glucose levels. The analysis leads to identifying iron deficiency anemia, prompting f

9 views • 22 slides

Guidelines and characteristics of invasive lobular carcinoma, focusing on oncological challenges, response to chemotherapy, and prognosis after neo-adjuvant treatment in patients. Highlights the importance of considering histology type for tailored treatment decisions. Discusses the effectiveness of

0 views • 20 slides

This guideline developed in collaboration with various oncology societies offers recommendations for partial breast irradiation (PBI) in patients with early-stage invasive breast cancer or ductal carcinoma in situ. It covers patient selection criteria, techniques for delivering PBI, dosing, and trea

1 views • 27 slides

Fibrolamellar Carcinoma (FLC) and Hepatocellular Carcinoma (HCC) are distinct liver cancers with important differences in age of onset, underlying causes, diagnostic markers, metastatic patterns, symptoms, treatment options, and outcomes. FLC primarily affects young and healthy individuals with no k

0 views • 4 slides

Testicular tumors are predominantly malignant, with germ cell tumors being the most common type. This article delves into the classification of testicular tumors, including primary and secondary, benign and malignant, germ cell, and non-germ cell tumors. Clinical findings such as painless enlargemen

3 views • 31 slides

Translational Liver Consortia (TLC) and the Translational Hepatocellular Carcinoma Consortium (THCCC) led by Dr. Hashem B. El-Serag are focused on advancing research for early detection of liver cancer. The main objectives include patient stratification for liver cancer risk, surveillance in cirrhos

0 views • 25 slides

A 23-year-old pregnant female presents with abdominal pain, leading to the diagnosis of pancreatoblastoma with liver metastasis. Initial biopsy and imaging confirm the presence of high-grade carcinoma, with treatment involving chemotherapy and stem cell transplant. CT features and a differential dia

0 views • 12 slides

Laryngeal tumours can be benign or malignant, with different types such as papilloma, chondroma, paraganglioma, and squamous cell carcinoma. These tumours present with various symptoms and may spread through direct, lymphatic, or hematogenous routes. Risk factors include tobacco smoking, alcohol con

0 views • 24 slides

Bladder tumours, particularly Transitional Cell Carcinoma (TCC), are the second most common cancer in the genitourinary system. Mainly caused by factors like cigarette smoking, industrial toxins, and genetic events, bladder cancer presents with symptoms such as hematuria and irritative voiding sympt

0 views • 26 slides

Ms. DR, a 62-year-old female with a history of tobacco use, presents with a right lung mass and possible metastatic disease. Imaging reveals a FDG-avid lung mass suspicious for primary malignancy. After obtaining informed consent, a CT-guided core biopsy is performed, showing cohesive, medium-sized

1 views • 16 slides

Parathyroid carcinoma (PC) is a rare malignancy often challenging to differentiate from benign thyroid nodules. This case study highlights a 50-year-old male patient whose nonfunctioning sporadic PC was initially misidentified as a follicular thyroid nodule. Despite preoperative evaluations, includi

4 views • 27 slides

Helicobacter pylori is a spiral-shaped Gram-negative bacterium associated with various gastrointestinal conditions like gastritis, duodenal ulcers, gastric ulcers, and gastric carcinoma. It exhibits unique characteristics in common with Campylobacters and has specific culture and growth requirements

0 views • 5 slides

Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor that requires specialized management. This comprehensive guide covers the clinical presentation, diagnosis, genetic aspects, and detailed management strategies for MTC, including surgical options, follow-up evaluation, and systemic the

0 views • 123 slides

Explore the essentials of gynaecological malignancies, including endometrial cancer, cervical carcinoma, ovarian cancer, vulval cancer, and more. Learn about government waiting time pledges, diagnostic procedures, treatment options like surgery, radiotherapy, and chemotherapy, referral networks, the

0 views • 38 slides

Mitotan 500 mg is a key medication for treating adrenocortical carcinoma, now available in India. This drug targets adrenal tumors, decreases hormone levels and inhibits cancer growth. Impomed Healthcare ensures the broad availability of Mitotan 500

1 views • 10 slides

Premalignant disease of the cervix is a significant health concern, particularly in developing countries. Carcinoma of the cervix ranks as the second most common cancer among women globally, with preventive measures vital for early detection and treatment. This article discusses the pathophysiology

0 views • 73 slides

Enfortumab vedotin 20\/30 mg is an innovative treatment for advanced urothelial carcinoma. Targeting the Nectin-4 protein, it delivers a cytotoxic agent directly to cancer cells, reducing toxicity to healthy tissues. Available in India, Enfortumab vedotin 20\/30 mg in India has shown improved surviv

0 views • 10 slides

In this detailed lecture, Assistant Professor Dr. Dalya Basil discusses the characteristics, identification methods, growth characteristics, and pathogenesis of Helicobacter pylori. This spiral-shaped, gram-negative rod bacterium is associated with various gastric conditions, including gastritis, ul

0 views • 23 slides

Exploring the use of mTOR inhibitors in liver transplantation for hepatocellular carcinoma (HCC), this content presents recent study results and experiences from the Korean population. It discusses the preventive potential of mTOR inhibitors in HCC recurrence based on previous studies and the need f

0 views • 32 slides

Prostate cancer, a significant health concern worldwide, has seen advancements in treatment with the adoption of IMRT. However, the use of radiotherapy poses risks of inducing secondary cancers due to organ toxicity. A study presented at ICARO3 focused on evaluating the toxicity of organs at risk an

0 views • 6 slides

Explore the spectrum of renal tumors, from benign papillary adenomas and oncocytomas to malignant renal cell carcinomas like clear cell carcinoma. Images and descriptions showcase the gross pathology and histopathology of these tumors. Learn about the features and prognosis of different renal tumor

0 views • 31 slides

Mitotane 500 mg Tablets are a vital treatment for individuals suffering from adrenocortical carcinoma, a rare cancer affecting the adrenal glands. These tablets work by suppressing hormone production, significantly alleviating symptoms and improving

2 views • 11 slides

This content delves into the changes in staging guidelines for head and neck malignancies as per the 8th edition of the AJCC/UICC criteria. It explores the modifications in staging for oropharynx cancer, neck metastatic disease, oral cavity depth of invasion, and cutaneous malignancies. The presenta

0 views • 32 slides

Mrs. B, a 49-year-old woman, was diagnosed with invasive ductal carcinoma in her left breast in December 2000. She underwent various treatments including surgery, chemotherapy, radiotherapy, and targeted therapies like Herceptin. Despite complications and ongoing pain, she has shown resilience throu

0 views • 32 slides